Delivery Order SPE2DE21D7020-SPE2D626F39CE

Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a delivery order under the Defense Health Agency's Medical Supply Chain blanket purchase agreement on February 2, 2026, with an ultimate completion date of February 9, 2026. This fixed-price delivery order, valued at $1,682.72 with economic price adjustment provisions, represents a task order issued against Boston Scientific's single-award BPA with the Defense Health Agency, which carries a $750,000 ceiling and extends through March 30, 2030. The delivery order was issued without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. The work will be performed at the contractor's facility in Marlborough, Massachusetts.

This delivery order aligns with Boston Scientific's established role as the sole supplier of radiation treatment devices under the Defense Health Agency's BPA, specifically fulfilling requirements for yttrium-90 glass microspheres, radiopharmaceuticals, and related radiation oncology equipment. The contract supports the federal government's medical supply chain continuity objectives across military healthcare facilities and Veterans Affairs medical centers, leveraging Boston Scientific's extensive portfolio of specialized medical device capabilities. As a global medical technology company with a comprehensive history of federal contracting with multiple Veterans Integrated Service Networks and federal healthcare entities, Boston Scientific provides critical cancer treatment modalities and specialized medical devices to defense and veterans healthcare enterprises.